TheraRadar
← Back
Data updated: Mar 29, 2026

GE HEALTHCARE

Infectious DiseaseNeurologyCardiovascular
Specialty

GE HEALTHCARE is a specialty pharmaceutical company focused on Infectious Disease, Neurology, Cardiovascular. Key products include VIZAMYL.

1951
Since
57
Drugs
-
Trials
20
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 28%
3 drugs
Neurology 25%
1 drugs Phase 3: 2 Phase 2: 1
Cardiovascular 20%
1 drugs Phase 3: 1 Phase 2: 1 Phase 1: 1
Oncology 17%
1 drugs Phase 2: 1 Phase 1: 3
Respiratory 9%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...